文献速递临床试验与 GCP

全膝关节置换术中高剂量糖皮质激素加入多模式鸡尾酒关节周围注射能否延长镇痛并改善恢复:随机对照试验方案

Would high-dose corticosteroid addition to multimodal cocktail periarticular injection contribute to prolonged pain control and better recovery following total knee arthroplasty?: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2021-10-15

本研究为双盲、随机、安慰剂对照试验方案,计划纳入234例拟行全膝关节置换术(TKA)的患者,比较鸡尾酒关节周围注射(MCPI)中加入高剂量倍他米松、常规剂量倍他米松及不加倍他米松三组在术后镇痛、功能改善、补救镇痛及不良反应方面的差异,并评估高剂量糖皮质激素是否带来更持久的疼痛控制与更好的恢复。

要点

  • 该方案拟纳入234例TKA患者,随机分为高剂量、常规剂量倍他米松MCPI及无倍他米松MCPI三组。
  • 主要观察指标包括术后90°屈膝时最强膝痛、步行能力、髌骨周径、KSS评分及CRP、血沉、血糖等。
  • 结果将为MCPI中含糖皮质激素的疗效及高剂量是否延长镇痛提供临床证据。

核心结论

  • 该试验方案旨在评估MCPI中加入高剂量糖皮质激素是否较常规剂量或不含糖皮质激素更能延长TKA术后镇痛并改善恢复。

研究设计与样本

  • 双盲、随机、安慰剂对照试验方案,计划招募234例拟行全膝关节置换术的患者。
  • 术中关闭伤口前向肌肉和关节囊注射80 ml鸡尾酒镇痛液行局部浸润镇痛。
  • 参与者随机分为高剂量倍他米松MCPI组(H组)、常规剂量倍他米松MCPI组(N组)和无倍他米松MCPI组(C组)。
  • 若参与者退出,将进行意向性治疗分析。

关键数值与推荐

  • 记录术后6小时、24小时、48小时、72小时、5天、14天和30天90°屈膝时最强膝痛。
  • 记录术后2、5、14和30天步行能力及髌骨周径。
  • 记录术后14天和30天膝关节协会评分(KSS)。
  • 检测C反应蛋白、血沉及术后2、5、14和30天血糖。
  • 记录补救镇痛药消耗量及不良事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Enhanced recovery following total knee arthroplasty (TKA) has been advocated to enhance postoperative recovery. Multimodal cocktail periarticular injection (MCPI) use for pain control in TKA has gained wide acceptance. MCPI-containing corticosteroids are believed to be an effective solution owing to their local anti-inflammatory effects and ability to reduce the local stress response postoperatively. However, there is conflicting evidence regarding its benefits. This trial aims to compare MCPI with a high dose of corticosteroid, normal dose of corticosteroid, and non-corticosteroid during TKA, to assess the effectiveness of MCPI containing corticosteroids in postoperative pain relief, functional improvement, rescue analgesia, and side effects and provide evidence that high-dose corticosteroids result in prolonged pain control and better recovery following TKA. METHODS: This is a double-blinded, randomized, placebo-controlled study. A total of 234 patients scheduled for TKA will be recruited. During surgery, before wound closure, 80 ml of the cocktail analgesic will be injected into the muscle and joint capsule for local infiltration analgesia; the participants will be randomly assigned to three groups to receive a high dose of betamethasone MCPI (group H), normal dose of betamethasone MCPI (group N), and non-betamethasone MCPI (group C). The following indices will be recorded and analyzed: the strongest knee pain experienced during 90° flexion at 6 h, 24 h, 48 h, 72 h, 5 days, 14 days, and 30 days after surgery; 1 min walking ability; and circumference around the patella at 2, 5, 14, and 30 days after surgery; Knee Society knee score at 14 days and 30 days after surgery; C-reactive protein and blood sedimentation; blood sugar 2, 5, 14, and 30 days following surgery; rescue analgesic consumption; and adverse events. If any participant withdraws from the trial, an intention-to-treat analysis will be performed. DISCUSSION: The results of this study will provide clinical evidence on the effectiveness of MCPI-containing corticosteroids in postoperative pain relief, functional improvement, rescue analgesia, and adverse events, as well as provide evidence on the efficacy of high-dose corticosteroids in prolonged pain control and better recovery following TKA. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR2000038671 . Registered on September 27, 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zhong C, He R, Lu X, et al. Would high-dose corticosteroid addition to multimodal cocktail periarticular injection contribute to prolonged pain control and better recovery following total knee arthroplasty?: study protocol for a randomized controlled trial. Trials. 2021. PMID: 34654469. doi:10.1186/s13063-021-05655-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。